Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Biovie Inc
BIVICurrent price
2.9 USD
-0.08 USD (-2.68%)
Last closed
2.95 USD
Company
www.biovieinc.com
ISIN
US09074F2074
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
19 144 802 USD
Yield for 12 month
-90.03 %
1Y
3Y
5Y
10Y
15Y
BIVI
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. Address: 680 West Nye Lane, Carson City, NV, United States, 89703
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-266 842 USD
Last Year
-237 421 USD
Current Quarter
-57 344 USD
Last Quarter
-57 344 USD
Key Figures BIVI
1 year
3 years
5 years
10 years
EBITDA
-38 136 700 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-62.32 %
PEG Ratio
–
Return On Equity TTM
-178.58 %
Wall Street Target Price
30 USD
Revenue TTM
–
Book Value
3.1 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-9.3 USD
Diluted Eps TTM
-9.3 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BIVI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIVI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
06.08.2024
Dividend Date
22.11.2019
Stock Valuation BIVI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-11.6556
Price Book MRQ
1.0213
Financials BIVI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BIVI
For 52 weeks
2.07 USD
58.2 USD
50 Day MA
3.37 USD
Shares Short Prior Month
100 002
200 Day MA
7.46 USD
Short Ratio
1
Shares Short
152 438
Short Percent
4.1 %
BeatStart